Predictors of treatment response in adolescents with comorbid substance use disorder and attention-deficit/hyperactivity disorder

Journal of Substance Abuse Treatment

Volumn 44, Issue 2, 2013, Pages 224-230

  Tamm, Leanne ^a   Trello Rishel, Kathlene ^b   Riggs, Paula ^c   Nakonezny, Paul A ^b,d   Acosta, Michelle ^e   Bailey, Genie ^f   Winhusen, Theresa ^g  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS AT DALLAS   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^e NATIONAL DEVELOPMENT AND RESEARCH INSTITUTES   (United States)

^f BROWN UNIVERSITY   (United States)

^g UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Attention Deficit Hyperactivity Disorder; Conduct disorder; OROS MPH; Predictors of treatment response; Substance Use Disorder

Indexed keywords

METHYLPHENIDATE; PLACEBO;

ADOLESCENT; ADOLESCENT HEALTH; ADULT; ARTICLE; ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; COMORBIDITY; CONDUCT DISORDER; COURT; DISEASE SEVERITY; DRUG DOSE ESCALATION; DRUG RELEASE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PATIENT COMPLIANCE; PRIORITY JOURNAL; SUBSTANCE ABUSE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADMINISTRATION, ORAL; ADOLESCENT; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDUCT DISORDER; DIAGNOSIS, DUAL (PSYCHIATRY); DRUG DELIVERY SYSTEMS; FEMALE; HUMANS; MALE; MANDATORY PROGRAMS; METHYLPHENIDATE; OSMOSIS; SEVERITY OF ILLNESS INDEX; SUBSTANCE-RELATED DISORDERS; TREATMENT OUTCOME;

EID: 84870691140     PISSN: 07405472     EISSN: 18736483     Source Type: Journal    
DOI: 10.1016/j.jsat.2012.07.001     Document Type: Article

References (59)

1. Adamson S.J., Sellman J.D., Frampton C.M. Patient predictors of alcohol treatment outcome: a systematic review. Journal of Substance Abuse Treatment 2009, 36:75-86.
2. Ahmadi J., Kampman K.M., Oslin D.M., Pettinati H.M., Dackis C., Sparkman T. Predictors of treatment outcome in outpatient cocaine and alcohol dependence treatment. American Journal on Addictions 2009, 18:81-86.
3. August G.J., Winters K.C., Realmuto G.M., Fahnhorst T., Botzet A., Lee S. Prospective study of adolescent drug use among community samples of ADHD and non-ADHD participants. Journal of the American Academy of Child and Adolescent Psychiatry 2006, 45:824-832.
4. Barkley R.A., Murphy K.R., Fischer M. Comorbid psychiatric disorders and psychological maladjustment ADHD in Adults. What the Science Says 2008, 205-244. Guilford Press, New York.
5. Biederman J., Newcorn J., Sprich S. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety, and other disorders. American Journal of Psychiatry 1991, 148:564-577.
6. Bostic J.Q., Biederman J., Spencer T.J., Wilens T.E., Prince J.B., Monuteaux M.C., et al. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short-term controlled trial. Journal of Child and Adolescent Psychopharmacology 2000, 10:205-216.
7. Brewer D.D., Catalano R.F., Haggerty K., Gainey R.R., Fleming C.B. A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction. Addiction 1998, 93:73-92.
8. Buitelaar J.K., Van der Gaag R.J., Swaab-Barneveld H., Kuiper M. Prediction of clinical response to methylphenidate in children with attention-deficit hyperactivity disorder. Journal of the American Academy of Child and Adolescent Psychiatry 1995, 34:1025-1032.
9. Burke A.C., Gregoire T.K. Substance abuse treatment outcomes for coerced and noncoerced clients. Health and Social Work 2007, 32:7-15.
10. Chambers W.J., Puig-Antich J., Hirsch M., Paez P., Ambrosini P.J., Tabrizi M.A., et al. The assessment of affective disorders in children and adolescents by semistructured interview. Test-retest reliability of the schedule for affective disorders and schizophrenia for school-age children, present episode version. Archives of General Psychiatry 1985, 42:696-702.
11. Ciraulo D.A., Piechniczek-Buczek J., Iscan E.N. Outcome predictors in substance use disorders. Psychiatric Clinics of North America 2003, 26:381-409.
12. Clark C., Young M.S. Outcomes of mandated treatment for women with histories of abuse and co-occurring disorders. Journal of Substance Abuse Treatment 2009, 37:346-352.
13. Crowley T.J., Mikulich S.K., MacDonald M., Young S.E., Zerbe G.O. Substance-dependent, conduct-disordered adolescent males: severity of diagnosis predicts 2-year outcome. Drug and Alcohol Dependence 1998, 49:225-237.
14. DuPaul G.J., Power T.J., Anastopoulos A.D., Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretation 1998, Guilford Press, New York.
15. Elkins I.J., McGue M., Iacono W.G. Prospective effects of attention-deficit/hyperactivity disorder, conduct disorder, and sex on adolescent substance use and abuse. Archives of General Psychiatry 2007, 64:1145-1152.
16. Ernst M., Luckenbaugh D.A., Moolchan E.T., Leff M.K., Allen R., Eshel N., et al. Behavioral predictors of substance-use initiation in adolescents with and without attention-deficit/hyperactivity disorder. Pediatrics 2006, 117:2030-2039.
17. Flory K., Lynam D.R. The relation between attention deficit hyperactivity disorder and substance abuse: what role does conduct disorder play?. Clinical Child and Family Psychology Review 2003, 6:1-16.
18. Goldkamp J.S., White M., Robinson J. Do Drug Courts Work? Getting inside the drug court black box. Journal of Drug Issues 2001, 31:27-72.
19. Gray K.M., Riggs P.D., Min S.J., Mikulich-Gilbertson S.K., Bandyopadhyay D., Winhusen T. Cigarette and cannabis use trajectories among adolescents in treatment for attention-deficit/hyperactivity disorder and substance use disorders. Drug and Alcohol Dependence 2011, 117:242-247.
20. Harty S.C., Ivanov I., Newcorn J.H., Halperin J.M. The impact of conduct disorder and stimulant medication on later substance use in an ethnically diverse sample of individuals with attention-deficit/hyperactivity disorder in childhood. Journal of Child and Adolescent Psychopharmacology 2011, 21:331-339.
21. Hinshaw S.P. Moderators and mediators of treatment outcome for youth with ADHD: understanding for whom and how interventions work. Journal of Pediatric Psychology 2007, 32:664-675.
22. Indig D., Copeland J., Conigrave K.M. Young people who attend specialist alcohol treatment: who are they and do they need special treatment?. Australian and New Zealand Journal of Public Health 2008, 32(4):336-340.
23. Jensen P.S., Hinshaw S.P., Kraemer H.C., Lenora N., Newcorn J.H., Abikoff H.B., et al. ADHD comorbidity findings from the MTA study: comparing comorbid subgroups. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40:147-158.
24. Klag S., O'Callaghan F., Creed P. The use of legal coercion in the treatment of substance abusers: an overview and critical analysis of thirty years of research. Substance Use & Misuse 2005, 40:1777-1795.
25. Klein R.G., Abikoff H., Klass E., Ganeles D., Seese L.M., Pollack S. Clinical efficacy of methylphenidate in conduct disorder with and without attention deficit hyperactivity disorder. Archives of General Psychiatry 1997, 54:1073-1080.
26. Kollins S.H., Jain R., Brams M., Segal S., Findling R.L., Wigal S.B., et al. Clonidine extended-release tablets as add-on therapy to psychostimulants in children and adolescents with ADHD. Pediatrics 2011, 127:e1406-e1413.
27. Kousha M., Shahrivar Z., Alaghband-Rad J. Substance Use Disorder and ADHD: Is ADHD a Particularly "Specific" Risk Factor?. Journal of Attention Disorders 2012, 16(4):325-332.
28. Latimer W.W., Newcomb M., Winters K.C., Stinchfield R.D. Adolescent substance abuse treatment outcome: the role of substance abuse problem severity, psychosocial, and treatment factors. Journal of Consulting and Clinical Psychology 2000, 68:684-696.
29. Lincour P., Kuettel T.J., Bombardier C.H. Motivational interviewing in a group setting with mandated clients: a pilot study. Addictive Behaviors 2002, 27:381-391.
30. Ling W., Shoptaw S., Wesson D., Rawson R.A., Compton M., Klett C.J. Treatment effectiveness score as an outcome measure in clinical trials. NIDA Research Monograph 1997, 175:208-220.
31. Loney J., Prinz R.J., Mishalow J., Joad J. Hyperkinetic/aggressive boys in treatment: predictors of clinical response to methylphenidate. American Journal of Psychiatry 1978, 135:1487-1491.
32. Mannuzza S., Klein R.G. Long-term prognosis in attention-deficit/hyperactivity disorder. Child and Adolescent Psychiatric Clinics of North America 2000, 9:711-726.
33. McKay J.R., Weiss R.V. A review of temporal effects and outcome predictors in substance abuse treatment studies with long-term follow-ups. Preliminary results and methodological issues. Evaluation Review 2001, 25:113-161.
34. Miller W.R., Del Boca F.K. Measurement of drinking behavior using the Form 90 family of instruments. Journal of Studies on Alcohol. Supplement 1994, 12:112-118.
35. Miller N.S., Flaherty J.A. Effectiveness of coerced addiction treatment (alternative consequences): a review of the clinical research. Journal of Substance Abuse Treatment 2000, 18:9-16.
36. Moffitt T.E. Juvenile delinquency and attention deficit disorder: boys' developmental trajectories from age 3 to age 15. Child Development 1990, 61:893-910.
37. National Institutes of Mental Health. (2010). from http://www.nimh.nih.gov/about/strategic-planning-reports/index.shtml.
38. Newcorn J.H., Halperin J.M., Jensen P.S., Abikoff H.B., Arnold L.E., Cantwell D.P., et al. Symptom profiles in children with ADHD: effects of comorbidity and gender. Journal of the American Academy of Child and Adolescent Psychiatry 2001, 40:137-146.
39. Nunes EV, Covey LS, Brigham G, Hu M, Pavlicova M, Levin FR. et al. (2011, under review). Treating nicotine dependence by targeting attention deficit hyperactivity disorder (ADHD): A placebo-controlled trial of methylphenidate.
40. Ohannessian C.M., Stabenau J.R., Hesselbrock V.M. Childhood and adulthood temperament and problem behaviors and adulthood substance use. Addictive Behaviors 1995, 20:77-86.
41. Ondersma S.J., Winhusen T., Lewis D.F. External pressure, motivation, and treatment outcome among pregnant substance-using women. Drug and Alcohol Dependence 2010, 107:149-153.
42. Orvaschel H. Schedule for Affective Disorders and Schizophrenia for School-Aged Children - Epidemiologic Version 5 (K-SADS-E) Instrument 1994, Nova Southeastern University, Ft. Lauderdale.
43. Owens E.B., Hinshaw S.P., Kraemer H.C., Arnold L.E., Abikoff H.B., Cantwell D.P., et al. Which treatment for whom for ADHD? Moderators of treatment response in the MTA. Journal of Consulting and Clinical Psychology 2003, 71:540-552.
44. Prince J.B., Wilens T.E., Biederman J., Spencer T.J., Millstein R., Polisner D.A., et al. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 2000, 10:193-204.
45. Riggs P.D., Mikulich S.K., Whitmore E.A., Crowley T.J. Relationship of ADHD, depression, and non-tobacco substance use disorders to nicotine dependence in substance-dependent delinquents. Drug and Alcohol Dependence 1999, 54:195-205.
46. Riggs P.D., Winhusen T., Davies R.D., Leimberger J.D., Mikulich-Gilbertson S., Klein C., et al. Randomized controlled trial of osmotic-release methylphenidate with cognitive-behavioral therapy in adolescents with attention-deficit/hyperactivity disorder and substance use disorders. Journal of the American Academy of Child and Adolescent Psychiatry 2011, 50:903-914.
47. Sobell L.C., Sobell M.B. Timeline Follow-Back: A technique for assessing self-reported alcohol consumption. Measuring Alcohol Consumption 1992, 207-224. The Humana Press, Inc, Rockville. R. Litten, J. Allen (Eds.).
48. Sullivan M.A., Rudnik-Levin F. Attention deficit/hyperactivity disorder and substance abuse. Diagnostic and therapeutic considerations. Annals of the New York Academy of Sciences 2001, 931:251-270.
49. Tamm L. Attention Deficit Hyperactivity Disorder. New Encyclopedia of Neuroscience 2009, 617-624. Academic Press, Oxford. L.R. Squire (Ed.).
50. Taylor E., Schachar R., Thorley G., Wieselberg H.M., Everitt B., Rutter M. Which boys respond to stimulant medication? A controlled trial of methylphenidate in boys with disruptive behaviour. Psychological Medicine 1987, 17:121-143.
51. Thompson L.L., Riggs P.D., Mikulich S.K., Crowley T.J. Contribution of ADHD symptoms to substance problems and delinquency in conduct-disordered adolescents. Journal of Abnormal Child Psychology 1996, 24:325-347.
52. Thurstone C., Riggs P.D., Salomonsen-Sautel S., Mikulich-Gilbertson S.K. Randomized, controlled trial of atomoxetine for attention-deficit/hyperactivity disorder in adolescents with substance use disorder. Journal of the American Academy of Child and Adolescent Psychiatry 2010, 49:573-582.
53. Timko C., Moos R.H. Symptom severity, amount of treatment, and 1-year outcomes among dual diagnosis patients. Administration and Policy in Mental Health 2002, 30:35-54.
54. Upadhyaya H.P., Rose K., Wang W., O'Rourke K., Sullivan B., Deas D., et al. Attention-deficit/hyperactivity disorder, medication treatment, and substance use patterns among adolescents and young adults. Journal of Child and Adolescent Psychopharmacology 2005, 15:799-809.
55. Whitmore E.A., Riggs P.D. Developmentally informed diagnostic and treatment considerations in comorbid conditions. Adolescent Substance Abuse: Research and Clinical Advances 2006, 264-283. Cambridge University Press, Cambridge. H.A. Liddle, C.L. Rowe (Eds.).
56. Wilens T.E. The nature of the relationship between attention-deficit/hyperactivity disorder and substance use. Journal of Clinical Psychiatry 2007, 68(Suppl. 11):4-8.
57. Winhusen T.M., Lewis D.F., Riggs P.D., Davies R.D., Adler L.A., Sonne S., et al. Subjective effects, misuse, and adverse effects of osmotic-release methylphenidate treatment in adolescent substance abusers with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology 2011, 21:455-463.
58. Winhusen T.M., Somoza E.C., Brigham G.S., Liu D.S., Green C.A., Covey L.S., et al. Impact of attention-deficit/hyperactivity disorder (ADHD) treatment on smoking cessation intervention in ADHD smokers: a randomized, double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry 2010, 71:1680-1688.
59. Wise B.K., Cuffe S.P., Fischer T. Dual diagnosis and successful participation of adolescents in substance abuse treatment. Journal of Substance Abuse Treatment 2001, 21:161-165.